Michael DeBaun, MD, MPH

Andrew Moreno

DocwireNews

Heme Today spoke with Michael R. DeBaun, MD, MPH, professor of pediatrics and medicine at Vanderbilt University School of Medicine in Nashville, Tennessee, and director of the Vanderbilt-Meharry Sickle Cell Disease Center of Excellence.
Dr. DeBaun was the chair of an American Society of Hematology (ASH) expert panel that conducted a systematic literature review regarding sickle cell trait (SCT), which was recently published in <a href="https://ashpublications.org/blood/article/doi/10.1182/blood.2024026899/535352/Sickle-Cell-Trait-Does-Not-Cause-Sickle-Cell">Blood</a>. The panel assessed whether clinicians are correct or incorrect to regard SCT as the direct cause of exertion-related mortality in patients who have SCT.
The ASH expert panel found that although researchers are only beginning to understand the complications associated with SCT, the data do not support the listing of SCT as a direct cause of death in patients who have SCT.
“Even within the field of pathology, they have recognized, since the mid-seventies, that the presence of sickle cells after death is artefactual, not factual,” Dr. DeBaun elaborated.
Regarding rhabdomyolysis as a complication observed in patients with SCT, Dr. DeBaun emphasized it can occur in patients with or without SCT, and it often manifests due to major physical injury rather than SCT.
“When rhabdomyolysis is identified in an individual with sickle cell trait, the cause of death is not the sickle cell trait but the presence of rhabdomyolysis, which can occur in patients without sickle cell trait, and then the sequelae associated with rhabdomyolysis,” Dr. DeBaun explained.
Dr. DeBaun described the panel’s finding that since at least the mid-1970s, SCT medical terminology has been misapplied. When patients who had SCT died, clinicians have often erroneously attributed death to SCT or “sickle cell crisis.” This is seen across disciplines including primary care, pediatrics, and pathology.
On the basis of these findings, Dr. DeBaun stresses that the training for new medical professionals must include better instruction about the implications of SCT for patients’ clinical outcomes. Patients also need to be correctly informed about what SCT means for their prognosis.
“We have failed to communicate to individuals at risk, individuals with sickle cell disease and sickle cell trait, to distinguish the adverse outcomes, none of which include dying of sickle cell trait as a direct cause or indirect cause, or dying from sickle cell crisis as a direct or indirect cause,” Dr. DeBaun said.

Ken Culver, MD

Kirk Smith

Cecilia Brown

ALK Positive Announces Formation of Scientific Advisory Board

ALK+ NSCLC

Phase 3 HARMONi-6/AK112-306 Trial of Ivonescimab Plus Chemotherapy for NSCLC Completes Enrollment

Immunotherapy in NSCLC

Mara B. Antonoff, MD, FACS

The Future of Surgery for Stage IV Lung Cancer: Dr. Antonoff Shares Hopes, Insights

Lung Cancer

Latest News

Michael DeBaun, MD, MPH, on Communicating the Meaning of Sickle Cell Trait for Patient Outcomes

Sickle Cell Disease

An expert panel's review finds SCT has often been misattributed as the direct cause of mortality in patients who have SCT.

About Us

Editorial Policy

Advertising

eNewsletters

Contribute

Contact Us

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

Mesothelioma

Non-Small Cell Lung Cancer

Small Cell Lung Cancer

Squamous Cell Lung Carcinoma

Lung Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

The Oncology Brothers

Rheumatology Rounds With Dr. Maheswaranathan

Healthcare Unfiltered

The Fellow on Call

Partners

Hurricanes & Health Care

Career Center

Expert Interviews

Subscribe